Default company panoramic image
Resized 20ktm 20logo

KitoTech Medical

We developed a disruptive wound closure product, microMend, which is superior to sutures & staples and gaining rapid sales growth since its launch in 2020.

  • Stage $1M in TTM Revenue
  • Industry Medical Devices and Equipment
  • Location Seattle, WA, USA
  • Currency USD
  • Founded November 2012
  • Employees 6
  • Incorporation Type C-corp
  • Website micromendskinclosure.com

Company Summary

KitoTech Medical launched its patented wound closure product microMend® into both medical & consumer markets in 2020. By incorporating tiny staples into a bandage, it closes wounds like a Band-Aid with strength of a stitch. On consumer side, partnered with CVS and Walgreens and strong Amazon sales. Corza Medical, one of largest wound closure companies, is our medical partner. Our total Q2 2022 revenues were $840k compared to $330k in Q1.

Team

  • Default avatar
    Paul Leung
    VP of Operations

    Paul has 19 years of experience in product and technology development as well as manufacturing in various industries, including several medical device companies. He currently serves as the Vice President of Operations of KitoTech Medical, where he is responsible for development and manufacturing. Paul received his Bachelor of Engineering degree with Honors at Imperial College London, and a Master of Science degree at Columbia University.​

  • Default avatar
    Gary Pruden
    Business Advisor

    Gary has held leadership positions across medical devices and pharmaceuticals at Johnson & Johnson for over 32 years. Most recently he was the Worldwide Chairman of J&J’s Medical Devices group, where he led a $20+ billion global business. He was also head of their Ethicon Division which holds 65% of the wound closure products worldwide market. He currently serves and advises multiple boards in healthcare. He is a graduate of Rider University.

  • Default avatar
    Eli Sonkin
    Director of Finance

    Eli leads finance and business operations at KitoTech. Before KitoTech, Eli led finance at several Seattle-based biotechnology and medical device companies. Previously, he spent 8 years in public accounting at Deloitte & Touche and E&Y. Eli has a BA in Business Administration from University of Washington, a Master’s in Accounting from Seattle University, and an MBA from the Haas School of Business at the University of California at Berkeley.​

  • Default avatar
    John Canady
    Chairman, Scientific Advisory Board

    John is a leading plastic surgeon who was previously Vice President of Medical Affairs at Johnson & Johnson, where he was employed for more than 10 years. Prior to J&J, he was on the faculty ( Plastics, Orthopedics, Rehabilitation Medicine Departments) at University of Iowa for 20 years. He has held the position of President of the American Society of Plastic Surgeons. He has a BS and Dec from Grinnell College, an MD from University of Iowa.

  • Default avatar
    Ed Truitt
    Chairman of Board

    Ed is a life sciences entrepreneur, who is CEO of Lubris BioPharma, which is developing an anti-inflammatory therapeutic protein. Lubris sold its ophthalmology portfolio to Novartis. Mr. Truitt is co-founder of Biological Dynamics on the Board and Sound Life Sciences. Previously, Mr. Truitt practiced corporate law, focusing on business formation and licensing. Mr. Truitt received his JD from University of San Diego and BA from UC Santa Barbara.

  • Fffecf18 10dd 4608 8ca8 2dc43457bbd1
    Director of Sales and Marketing

    Anita has over 25 years of sales and marketing experience including senior management positions in the medical device industry in wound closure products and disposables. She has worked with KitoTech as a consultant for over 2 years and has been instrumental in developing and implementing commercial strategies for our medical and consumer businesses. Anita is a graduate of the University of Southern Denmark.

Advisors

  • Default avatar
    Ed Truitt, JD
    Unconfirmed
    Default avatar
    Marco Rolandi, PhD
    Unconfirmed
    Default avatar
    Val Warhaft, MD
    Unconfirmed
  • Default avatar
    Linda Mihalov, MD
    Unconfirmed
    Default avatar
    Silas Chiu, MD
    Unconfirmed
    Default avatar
    Dan Wahl, DO
    Unconfirmed
  • Default avatar
    Chris Hartzog
    Unconfirmed
    Default avatar
    Chris Nichols, MD
    Unconfirmed
  • Default avatar
    Pritesh Shah, PharmD
    Unconfirmed
    Default avatar
    Ryan Ahern, MD
    Unconfirmed
  • Default avatar
    Baruch Fertel, MD
    Unconfirmed
  • Default avatar
    Gary Pruden
    Unconfirmed
    Default avatar
    Ron Moy, MD
    Unconfirmed
  • Default avatar
    Daniel Behroozan, MD
    Unconfirmed
    Default avatar
    George Hruza, MD
    Unconfirmed
    Default avatar
    Nirav Shah, MD
    Unconfirmed

Previous Investors

  • Default avatar
    Michigan Capital Network Venture Funds
    Unconfirmed
    Default avatar
    United Enterprise Investment
    Unconfirmed
    Default avatar
    Global Medical Alliance
    Unconfirmed
  • Default avatar
    TIE Capital
    Unconfirmed
    Default avatar
    Global Medical Alliance
    Unconfirmed
    Default avatar
    Keiretsu Capital
    Unconfirmed
  • Default avatar
    Kyto Technologies and Life Sciences
    Unconfirmed
    Default avatar
    WaterStar Capital
    Unconfirmed
    Default avatar
    ITIC
    Unconfirmed
  • Default avatar
    UEI
    Unconfirmed
    Default avatar
    South Coast Angel Network
    Unconfirmed
  • Default avatar
    Kyto Technology and Life Science (no relation to KitoTech Medical)
    Unconfirmed
    Default avatar
    Cornerstone Angels
    Unconfirmed
  • Default avatar
    Heartland Angels
    Unconfirmed
    Default avatar
    ARCH Angels
    Unconfirmed
  • Default avatar
    George.hruza@unite
    Unconfirmed
    Default avatar
    Lehigh Valley Angel Investors
    Unconfirmed
  • Default avatar
    Bellingham Angel Investors
    Unconfirmed